Clinical Trial Update: Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of PurTox Botulinum Toxin Type A for treating glabellar frown lines completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Rhytides

Drugs mentioned

• PurTox Botulinum Toxin Type A (Botulinum toxin type A)

Snippet

Sponsor: Mentor Worldwide, LLC | Conditions: Glabellar Rhytides | Phase 3 | Status: COMPLETED